Literature DB >> 19729171

Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation.

J H Choi1, H Mast, A Hartmann, R S Marshall, J Pile-Spellman, J P Mohr, C Stapf.   

Abstract

OBJECTIVE: Some patients with brain arteriovenous malformation (BAVM) present with focal neurological deficits (FNDs) unrelated to clinically discernable seizure activity or hemorrhage. The aim of this study is to determine demographic and morphological AVM characteristics associated with FNDs.
METHODS: The 735 patients of the prospective Columbia AVM Databank were analyzed. Univariate and multivariate statistical models were used to test the association of demographic (age, gender), and morphological characteristics (BAVM size, anatomic location, arterial supply, venous drainage pattern, venous ectasia) with the occurrence of FNDs at the time of initial BAVM diagnosis.
RESULTS: Fifty-three patients (7%, mean age 40+/-16years, 70% women) presented with FNDs. The multivariate logistic regression model revealed an independent association of FNDs with increasing age (OR 1.03; 95%-CI 1.00-1.05), female gender (OR 2.14; 95%-CI 1.15-3.97), deep brain location (OR 2.46; 95%-CI 1.24-4.88), brainstem location (OR 5.62; 95%-CI 1.65-19.23), and venous ectasia (OR 1.91; 95%-CI 1.01-3.64). No association was found for BAVM size, lobar location, arterial supply and venous drainage pattern.
INTERPRETATION: Focal neurologic deficits unrelated to seizures or hemorrhage are a rare initial presentation of BAVMs. The predominance of FNDs among brainstem and deeply located BAVMs and the lack of a significant association of BAVM size with FNDs indicate selective white matter pathway-specific vulnerability, the association with patient age a time dependent effect. The higher frequency of FNDs among women suggests gender-specificity of brain tissue vulnerability.

Entities:  

Mesh:

Year:  2009        PMID: 19729171      PMCID: PMC2783734          DOI: 10.1016/j.jns.2009.08.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

1.  Distributions of local oxygen saturation and its response to changes of mean arterial blood pressure in the cerebral cortex adjacent to arteriovenous malformations.

Authors:  B Meyer; C Schaller; C Frenkel; B Ebeling; J Schramm
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

2.  Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials.

Authors:  R P Atkinson; I A Awad; H H Batjer; C F Dowd; A Furlan; S L Giannotta; C R Gomez; D Gress; G Hademenos; V Halbach; J C Hemphill; R T Higashida; L N Hopkins; M B Horowitz; S C Johnston; M W Lawton; M W McDermott; A M Malek; J P Mohr; A I Qureshi; H Riina; W S Smith; J Pile-Spellman; R F Spetzler; T A Tomsick; W L Young
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

3.  Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation.

Authors:  C Hofmeister; C Stapf; A Hartmann; R R Sciacca; U Mansmann; K terBrugge; P Lasjaunias; J P Mohr; H Mast; J Meisel
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

4.  The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.

Authors:  S L Ondra; H Troupp; E D George; K Schwab
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

5.  Effects of cerebral angiomas on perifocal and remote tissue: a multivariate positron emission tomography study.

Authors:  G R Fink
Journal:  Stroke       Date:  1992-08       Impact factor: 7.914

6.  Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation.

Authors:  C Stapf; A V Khaw; R R Sciacca; C Hofmeister; H C Schumacher; J Pile-Spellman; H Mast; J P Mohr; A Hartmann
Journal:  Stroke       Date:  2003-10-23       Impact factor: 7.914

7.  Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations.

Authors:  R D Lobato; J J Rivas; P A Gomez; A Cabrera; R Sarabia; E Lamas
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

8.  Arteriovenous malformation and diaschisis.

Authors:  K Tanaka; Y Yonekawa; Y Kaku; K Kazekawa
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  The New York Islands AVM Study: design, study progress, and initial results.

Authors:  C Stapf; H Mast; R R Sciacca; A Berenstein; P K Nelson; Y P Gobin; J Pile-Spellman; J P Mohr
Journal:  Stroke       Date:  2003-04-10       Impact factor: 7.914

10.  Cerebral hemodynamics and metabolism in patients with cerebral arteriovenous malformations: an evaluation using positron emission tomography scanning.

Authors:  Toru Iwama; Kohei Hayashida; Jun C Takahashi; Izumi Nagata; Nobuo Hashimoto
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

View more
  7 in total

1.  Risk factors of intracranial hemorrhage after brain AVM interventional therapy and its effects on prognosis.

Authors:  Guobin Li; Kun Han; Haiying Yang; Hui Huang; Hong Yang; Dezhang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

3.  Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines.

Authors:  Xianbin Ning; Changfu Zhao; Jinfeng Pang; Zhaoyi Ding; Yubo Wang; Kan Xu; Hao Chen; Bingwei Li; Q I Luo
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

4.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

5.  Arteriovenous malformation and dementia: A case report.

Authors:  Sonia Maria Dozzi Brucki; Samila Marissa Pinheiro Gomes
Journal:  Dement Neuropsychol       Date:  2016 Jul-Sep

6.  Cerebral arteriovenous malformation presenting as isolated bilateral pupil-sparing oculomotor, pseudoabducens palsy, and hemiataxia.

Authors:  I-Hsu Chen; Yi-Hui Lin; Meng-Ni Wu; Chiou-Lian Lai; Li-Min Liou
Journal:  Neurol Sci       Date:  2018-02-17       Impact factor: 3.307

7.  The ARUBA trial: current status, future hopes.

Authors:  J P Mohr; Alan J Moskowitz; Christian Stapf; Andreas Hartmann; Karen Lord; Steven M Marshall; Henning Mast; Ellen Moquete; Claudia Scala Moy; Michael Parides; John Pile-Spellman; Rustam Al-Shahi Salman; Alan Weinberg; William L Young; Alejandrina Estevez; Inam Kureshi; Jonathan L Brisman
Journal:  Stroke       Date:  2010-07-15       Impact factor: 7.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.